Ancora Heart Appoints Mark Miles as Chief Commercial Officer · BioBuzz biobuzz.io - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biobuzz.io Daily Mail and Mail on Sunday newspapers.
Designation Allows for Expedited Review of Transcatheter Therapy Designed to Improve Left Ventricular Structure and Function in Heart Failure Patients with Reduced Ejection Fraction
Designation Allows for Expedited Review of Transcatheter Therapy Designed to Improve Left Ventricular Structure and Function in Heart Failure Patients with Reduced Ejection FractionSANTA CLARA, Calif. (BUSINESS WIRE) #accucinch Ancora Heart, Inc., a company developing a novel device-based therapy to address heart.